Baystate Medical Center INC

Baystate Medical Center INC was paid $374.47M by Medicaid between Jan 2018 and Dec 2024, across 895 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 19% of everything it billed.

33Billing provider infoBAYSTATE MEDICAL CENTER INC
SPRINGFIELD, MA 01199

33aNPI1487655064assigned 08/09/2005

33bProvider typeClinic/Center

28Total paid$374.47M

24GClaims7,805,534

24DCodes billed895

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Clinic/Center providers in Massachusetts

Rank by total paid#1 of 53

Median peer was paid$154K

This provider vs. median2,433×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,200,587	$63.54M
2019	1,707,423	$57.14M
2020	912,078	$43.21M
2021	1,056,230	$51.64M
2022	1,179,188	$63.40M
2023	1,005,808	$51.04M
2024incomplete	744,220	$44.49M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	19%	495,590	414,086	$72.38M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	4.9%	117,580	106,439	$18.23M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.6%	87,551	77,662	$17.12M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	4.6%	108,518	100,728	$17.12M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	3.5%	95,197	86,886	$13.28M
96361	Intravenous infusion, hydration; each additional hour	3.1%	37,935	25,733	$11.77M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	2.1%	235,418	189,958	$7.68M
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	1.7%	41,112	34,276	$6.21M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.4%	83,650	27,258	$5.25M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.4%	29,448	22,371	$5.16M
96415		1.4%	9,844	7,511	$5.14M
59025	Fetal non-stress test	1.3%	19,842	13,001	$4.81M

883 more codes

G0378	Hospital observation service, per hour	1.3%	38,459	$4.69M
99213	Doctor's office visit, returning patient (routine)	1.2%	37,056	$4.61M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.2%	24,823	$4.41M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.0%	5,527	$3.92M
41899	Unlisted procedure, dentoalveolar structures	<1%	2,406	$3.50M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	55,597	$3.44M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	12,645	$3.42M
S9485	Crisis intervention mental health services, per diem	<1%	8,513	$3.40M
70450	Computed tomography, head or brain; without contrast material	<1%	24,049	$3.04M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	23,005	$3.00M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	51,190	$2.76M
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	24,289	$2.65M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	23,228	$2.32M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	2,530	$2.24M
95811		<1%	3,134	$2.21M
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	1,199	$2.17M
J9271	Injection, pembrolizumab, 1 mg	<1%	216	$2.05M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	11,088	$2.05M
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	16,864	$1.90M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	46,204	$1.86M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	19,052	$1.81M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	2,872	$1.81M
95806		<1%	2,806	$1.80M
93971		<1%	9,678	$1.78M
77063	Screening digital breast tomosynthesis, bilateral	<1%	26,955	$1.77M
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	18,363	$1.73M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	13,492	$1.70M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	26,490	$1.60M
58661		<1%	471	$1.60M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	12,288	$1.53M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	69,767	$1.50M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	1,380	$1.49M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	59,051	$1.47M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	58,742	$1.47M
J2357	Injection, omalizumab, 5 mg	<1%	4,068	$1.46M
76770		<1%	9,169	$1.45M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	14,033	$1.44M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	10,028	$1.40M
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	14,643	$1.39M
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	14,673	$1.26M
76819	Fetal biophysical profile; without non-stress testing	<1%	13,779	$1.25M
62323		<1%	3,332	$1.24M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	9,152	$1.21M
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	6,533	$1.19M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	252,214	$1.17M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	4,434	$1.16M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	3,191	$1.14M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,331	$1.11M
97161		<1%	16,099	$1.11M
76642		<1%	10,109	$1.11M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	58,342	$1.10M
93458		<1%	1,173	$1.09M
87631		<1%	13,958	$1.08M
76830	Ultrasound, transvaginal	<1%	10,609	$1.07M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	15,121	$1.03M
43235		<1%	1,617	$982K
99214	Doctor's office visit, returning patient (more involved)	<1%	8,653	$980K
93308		<1%	5,124	$979K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	2,619	$964K
96367		<1%	5,413	$953K
93970		<1%	4,302	$940K
H0035	Mental health partial hospitalization, treatment, less than 24 hours	<1%	3,316	$931K
95886		<1%	4,405	$909K
71046	Radiologic examination, chest; 2 views	<1%	66,337	$906K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	3,506	$897K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	5,606	$893K
71275	Computed tomographic angiography, chest, with contrast material	<1%	4,945	$832K
70496		<1%	4,606	$812K
76801		<1%	7,285	$801K
36430		<1%	2,945	$789K
84443	Thyroid stimulating hormone (TSH)	<1%	79,257	$771K
93975		<1%	10,164	$757K
90834	Psychotherapy session, about 45 minutes	<1%	9,936	$750K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	20,949	$728K
97162		<1%	11,587	$703K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	4,973	$700K
64415		<1%	1,708	$700K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	28,612	$681K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	1,479	$672K
93798		<1%	15,150	$661K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	5,409	$656K
87481		<1%	14,187	$646K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	8,219	$644K
76536		<1%	5,220	$603K
93325		<1%	5,973	$599K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	33,670	$593K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	9,671	$579K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	9,827	$572K
94060		<1%	5,351	$569K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	8,615	$567K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	1,610	$566K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	20,484	$547K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	194	$546K
76813		<1%	4,243	$533K
97803		<1%	7,359	$532K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	6,177	$531K
97802		<1%	7,143	$529K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	9,517	$524K
54161		<1%	296	$517K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	61,952	$506K
81513		<1%	7,246	$502K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	3,059	$492K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	114,505	$488K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,060	$484K
80051		<1%	110,577	$461K
19083		<1%	354	$440K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	1,458	$438K
90686		<1%	52,511	$431K
12011		<1%	1,835	$425K
95708		<1%	1,147	$419K
83036	Hemoglobin; glycosylated (A1C)	<1%	83,471	$418K
90715		<1%	20,992	$417K
99201		<1%	2,921	$416K
76942		<1%	8,792	$413K
80053	Comprehensive metabolic panel	<1%	90,869	$406K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	24,134	$405K
12001		<1%	1,832	$404K
71250		<1%	5,586	$399K
83880		<1%	23,551	$399K
84484		<1%	59,021	$399K
93304		<1%	1,424	$398K
99381		<1%	3,027	$391K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	18,247	$389K
96402		<1%	694	$387K
95953		<1%	562	$384K
77412		<1%	2,490	$381K
85027		<1%	90,330	$371K
93017		<1%	4,502	$367K
96375	Therapeutic injection; each additional sequential IV push	<1%	55,840	$366K
58300		<1%	1,407	$366K
77336		<1%	5,566	$363K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	855	$360K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	6,439	$350K
87086	Culture, bacterial; quantitative colony count, urine	<1%	59,656	$340K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	14,748	$337K
90791	Psychiatric diagnostic evaluation	<1%	2,573	$337K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,445	$335K
97597		<1%	6,382	$326K
97165		<1%	3,404	$322K
77065	Tomosynthesis, mammo	<1%	6,556	$321K
92587		<1%	2,684	$311K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	117,991	$308K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	2,675	$305K
20552		<1%	1,536	$292K
74183		<1%	717	$288K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,821	$283K
80048	Basic metabolic panel (calcium, ionized)	<1%	80,882	$280K
83605		<1%	38,376	$280K
72100		<1%	7,830	$278K
86780		<1%	27,186	$278K
87536		<1%	6,143	$275K
76870		<1%	2,765	$275K
20610		<1%	1,650	$274K
V5160	Dispensing fee, binaural	<1%	676	$274K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	10,055	$270K
88307		<1%	3,334	$267K
V5261	Hearing aid, digital, binaural, bte	<1%	526	$266K
81025		<1%	43,959	$257K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	3,670	$256K
94726		<1%	5,473	$253K
95782		<1%	237	$248K
V5266	Battery for use in hearing device	<1%	4,029	$247K
64445		<1%	999	$247K
87088		<1%	29,640	$246K
94729		<1%	5,473	$242K
86481		<1%	4,589	$241K
86480		<1%	5,569	$235K
77061		<1%	2,283	$224K
93922		<1%	4,151	$222K
86803		<1%	22,761	$221K
44970		<1%	65	$220K
77386		<1%	1,065	$217K
64721		<1%	291	$217K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,768	$216K
94375		<1%	4,135	$216K
58301		<1%	850	$209K
84702		<1%	18,298	$207K
81001		<1%	98,521	$206K
82565		<1%	125,656	$204K
77062		<1%	2,078	$203K
77080		<1%	4,404	$200K
11982		<1%	888	$196K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	37,553	$192K
83690		<1%	43,103	$191K
Q3014	Telehealth originating site facility fee	<1%	46,683	$188K
74018		<1%	7,740	$187K
86850		<1%	29,711	$186K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	243	$186K
92552		<1%	6,977	$182K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	15,870	$182K
0001A		<1%	6,021	$176K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	1,999	$173K
83735		<1%	47,930	$173K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	8,426	$171K
76882		<1%	1,450	$168K
87653		<1%	5,668	$167K
0002A		<1%	5,615	$166K
72141		<1%	561	$164K
97014		<1%	1,896	$163K
82728		<1%	20,366	$163K
97035		<1%	2,489	$160K
27447		<1%	28	$158K
73630		<1%	8,133	$158K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	27,633	$157K
12002		<1%	699	$156K
20553		<1%	683	$155K
83655		<1%	13,501	$154K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	15,667	$154K
64615		<1%	513	$152K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	1,682	$152K
73130		<1%	7,909	$151K
97166		<1%	1,538	$148K
11981		<1%	488	$148K
93225		<1%	2,791	$147K
73030		<1%	7,855	$146K
73560		<1%	8,832	$146K
70491		<1%	1,035	$144K
51725		<1%	488	$144K
73610		<1%	7,872	$143K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	4,427	$143K
93880		<1%	2,425	$142K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	<1%	216	$141K
96523		<1%	3,430	$140K
92523		<1%	1,050	$140K
72040		<1%	3,582	$140K
87040		<1%	17,982	$138K
82607		<1%	17,117	$136K
84439		<1%	24,464	$136K
84520		<1%	110,468	$136K
80061	Lipid panel	<1%	35,083	$136K
99383		<1%	1,368	$135K
47562		<1%	37	$134K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	181	$134K
71045	Radiologic examination, chest; single view	<1%	20,796	$133K
84703		<1%	24,358	$133K
76825		<1%	1,087	$130K
J1644	Injection, heparin sodium, per 1000 units	<1%	21,332	$129K
ATP14		<1%	19,110	$128K
64447		<1%	835	$127K
90651		<1%	11,107	$126K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	65,124	$125K
J0690	Injection, cefazolin sodium, 500 mg	<1%	30,871	$125K
99385		<1%	1,323	$124K
J2704	Injection, propofol, 10 mg	<1%	54,474	$123K
95816		<1%	387	$121K
J0485	Injection, belatacept, 1 mg	<1%	455	$121K
87340		<1%	16,618	$120K
87522	Neg quan hep c or qual rna	<1%	3,997	$120K
90662		<1%	4,351	$118K
90674		<1%	5,525	$115K
71271		<1%	2,824	$115K
82947		<1%	79,200	$114K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	3,789	$113K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	111	$110K
77300		<1%	869	$110K
77066	Tomosynthesis, mammo	<1%	3,972	$109K
70498		<1%	4,458	$108K
76775		<1%	1,378	$108K
87081		<1%	18,549	$107K
76604		<1%	1,257	$107K
58558		<1%	58	$105K
86140		<1%	26,473	$103K
84460		<1%	62,434	$103K
ATP08		<1%	17,453	$102K
90677		<1%	4,358	$101K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	40,445	$100K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	23,875	$99K
69209		<1%	1,404	$98K
86923		<1%	2,144	$97K
20680		<1%	82	$97K
88342		<1%	4,728	$96K
10060		<1%	545	$95K
73110		<1%	5,049	$95K
86003		<1%	1,569	$94K
86762		<1%	8,000	$94K
76820		<1%	1,907	$94K
72125	Computed tomography, cervical spine; without contrast material	<1%	10,329	$93K
84450		<1%	57,824	$93K
92567		<1%	3,257	$93K
29824		<1%	94	$93K
99384		<1%	932	$93K
90837	Psychotherapy session, about an hour	<1%	934	$92K
86360		<1%	4,242	$91K
73502		<1%	4,724	$89K
70486		<1%	2,350	$87K
64493		<1%	139	$87K
87186		<1%	15,172	$87K
85610		<1%	46,213	$87K
83970		<1%	5,212	$87K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	1,563	$87K
73562		<1%	2,552	$85K
27130		<1%	13	$84K
V5264	Ear mold/insert, not disposable, any type	<1%	1,076	$84K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	37	$83K
J1170	Injection, hydromorphone, up to 4 mg	<1%	24,816	$83K
57454		<1%	226	$82K
99188		<1%	6,139	$81K
ATP07		<1%	12,573	$81K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	30,884	$81K
76885		<1%	550	$80K
76857		<1%	898	$80K
92250		<1%	7,197	$78K
83550		<1%	15,891	$78K
82570		<1%	29,748	$78K
90670		<1%	16,144	$77K
74220		<1%	1,187	$77K
97016		<1%	959	$77K
83013		<1%	1,481	$76K
93926		<1%	529	$75K
64450		<1%	400	$75K
96368		<1%	2,545	$74K
86355		<1%	4,250	$74K
86357		<1%	4,237	$73K
86359		<1%	4,232	$73K
94660		<1%	723	$72K
86317		<1%	6,733	$72K
90732		<1%	2,663	$71K
82330		<1%	9,864	$70K
G0008	Administration of influenza virus vaccine	<1%	10,179	$70K
87486		<1%	2,823	$70K
80305		<1%	10,530	$70K
87581		<1%	2,828	$70K
93226		<1%	2,815	$69K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	42,132	$69K
88341		<1%	1,635	$69K
86900		<1%	27,106	$68K
82784		<1%	9,129	$68K
92550		<1%	903	$67K
82247		<1%	43,681	$67K
29826		<1%	94	$65K
83540		<1%	17,529	$65K
83021		<1%	4,172	$64K
83718		<1%	11,567	$64K
86787		<1%	6,000	$64K
82746		<1%	7,954	$63K
87210		<1%	15,523	$63K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	16,753	$63K
92557		<1%	1,259	$62K
90472	Immunization administration, each additional vaccine (list separately)	<1%	44,822	$62K
76827		<1%	1,055	$62K
80076		<1%	18,850	$61K
17250		<1%	502	$61K
0124A		<1%	2,450	$59K
87480		<1%	3,882	$58K
77334		<1%	383	$58K
29125		<1%	375	$58K
93296		<1%	2,073	$58K
87510		<1%	3,880	$58K
87660		<1%	3,866	$57K
84403		<1%	3,217	$57K
87070		<1%	9,486	$56K
64417		<1%	129	$54K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	12,747	$54K
0054A		<1%	1,822	$54K
82043		<1%	20,662	$54K
85730		<1%	15,887	$54K
85379		<1%	8,747	$53K
86901		<1%	27,016	$53K
84075		<1%	33,297	$52K
95910		<1%	966	$51K
90480		<1%	1,276	$51K
83516		<1%	4,191	$51K
73140		<1%	2,010	$50K
90746		<1%	2,200	$50K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	30	$50K
82105		<1%	3,550	$49K
36415	Collection of venous blood by venipuncture	<1%	164,644	$48K
73080		<1%	3,680	$48K
91320		<1%	904	$47K
86704		<1%	6,444	$46K
90832	Psychotherapy session, about 30 minutes	<1%	1,059	$46K
85652		<1%	24,398	$45K
19081		<1%	43	$45K
75574		<1%	363	$44K
72072		<1%	1,316	$44K
80050	General health panel	<1%	2,774	$44K
87147		<1%	10,251	$43K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	7,269	$43K
0004A		<1%	1,681	$43K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	334	$43K
96118		<1%	93	$43K
99382		<1%	463	$43K
ATP11		<1%	7,026	$42K
Q5108	Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg	<1%	21	$42K
97012		<1%	576	$41K
81003		<1%	26,690	$41K
74240		<1%	221	$41K
82803		<1%	2,623	$40K
49083		<1%	90	$40K
10005		<1%	118	$40K
52356		<1%	14	$40K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	116	$40K
84146		<1%	2,689	$39K
ATP15		<1%	5,788	$39K
74174		<1%	350	$39K
87529		<1%	1,020	$38K
87077		<1%	10,204	$37K
58100		<1%	134	$36K
95819		<1%	116	$36K
92579		<1%	856	$35K
83001		<1%	2,334	$34K
96040		<1%	1,050	$33K
0071A		<1%	725	$33K
84153		<1%	3,791	$33K
54150		<1%	15	$32K
ATP17		<1%	6,185	$31K
73590		<1%	3,547	$31K
74230		<1%	214	$30K
90656		<1%	2,564	$30K
83721		<1%	6,895	$30K
J3490	Unclassified drugs	<1%	10,498	$30K
82465		<1%	12,154	$30K
82950		<1%	7,078	$30K
96411		<1%	1,800	$30K
97116		<1%	927	$29K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	309	$29K
86618		<1%	2,353	$28K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	2,119	$27K
42830		<1%	13	$27K
27096		<1%	65	$27K
81508		<1%	1,515	$27K
0072A		<1%	631	$27K
82670		<1%	1,236	$27K
87902		<1%	241	$26K
86038		<1%	3,106	$26K
0031A		<1%	883	$26K
ATP06		<1%	4,459	$26K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	22,665	$25K
58340		<1%	37	$25K
G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	<1%	927	$25K
90734		<1%	8,665	$25K
49450		<1%	69	$25K
82962		<1%	69,771	$24K
93797		<1%	772	$24K
84100		<1%	18,871	$24K
90714		<1%	963	$23K
82550		<1%	10,442	$23K
88173		<1%	707	$23K
95885		<1%	87	$23K
87205		<1%	7,741	$22K
ATP09		<1%	3,704	$22K
77002		<1%	264	$22K
72170		<1%	1,810	$22K
84481		<1%	1,972	$22K
J2182	Injection, mepolizumab, 1 mg	<1%	26	$22K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	12,055	$22K
86708		<1%	2,751	$22K
97535	Self-care/home management training, each 15 minutes	<1%	401	$22K
96417		<1%	5,668	$22K
93923		<1%	251	$21K
83002		<1%	1,483	$21K
94664		<1%	1,893	$21K
80179		<1%	2,749	$21K
84163		<1%	1,671	$21K
82150		<1%	4,894	$21K
84156		<1%	9,803	$21K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	3,250	$21K
0052A		<1%	537	$21K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	878	$20K
96416		<1%	157	$20K
80074		<1%	679	$20K
29881		<1%	12	$20K
86665		<1%	1,101	$20K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	130	$20K
82010		<1%	3,659	$19K
J3370	Injection, vancomycin hcl, 500 mg	<1%	5,306	$19K
81002		<1%	7,109	$19K
80164		<1%	2,762	$19K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	3,828	$19K
ATP10		<1%	4,506	$19K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	127	$18K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	65	$18K
72131		<1%	690	$18K
88112		<1%	517	$18K
99218		<1%	750	$18K
80047		<1%	6,143	$17K
88304		<1%	5,670	$17K
ATP03		<1%	6,644	$17K
82785		<1%	1,428	$17K
84270		<1%	1,142	$17K
86334		<1%	1,992	$17K
97804		<1%	281	$16K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	716	$16K
96133		<1%	76	$16K
86765		<1%	1,665	$16K
93978		<1%	341	$16K
ATP04		<1%	3,215	$15K
82378		<1%	1,492	$15K
87075		<1%	2,526	$15K
77290		<1%	49	$15K
73090		<1%	2,699	$15K
85045		<1%	5,079	$15K
10022		<1%	45	$14K
V5267	Hearing aid or assistive listening device/supplies/accessories, not otherwise specified	<1%	1,559	$14K
86735		<1%	1,432	$14K
0051A		<1%	361	$14K
ATP02		<1%	3,954	$14K
86580		<1%	596	$13K
82248		<1%	10,662	$13K
96139		<1%	87	$13K
J3489	Injection, zoledronic acid, 1 mg	<1%	556	$13K
82040		<1%	8,366	$13K
84132		<1%	8,841	$13K
82310		<1%	8,509	$13K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	2,073	$13K
83615		<1%	7,554	$13K
83520		<1%	1,155	$13K
95700		<1%	689	$12K
87046		<1%	809	$12K
51784		<1%	77	$12K
J2060	Injection, lorazepam, 2 mg	<1%	10,362	$12K
90707		<1%	4,894	$12K
95912		<1%	149	$12K
85014		<1%	8,107	$12K
86376		<1%	1,139	$11K
90632		<1%	3,575	$11K
87507		<1%	31	$11K
87517		<1%	485	$11K
82274		<1%	1,563	$11K
96401		<1%	86	$11K
74019		<1%	600	$11K
90649		<1%	861	$11K
85018		<1%	5,586	$10K
82140		<1%	1,364	$10K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	1,436	$10K
92611		<1%	156	$10K
77072		<1%	116	$10K
J1630	Injection, haloperidol, up to 5 mg	<1%	8,774	$10K
86664		<1%	739	$10K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	88	$10K
11721		<1%	280	$10K
90716		<1%	4,627	$10K
77280		<1%	89	$9K
77295		<1%	12	$9K
80069		<1%	5,386	$9K
84550		<1%	6,857	$9K
Q0114	Fern test	<1%	1,702	$9K
72158		<1%	55	$9K
82652		<1%	454	$9K
72050		<1%	168	$9K
92558		<1%	65	$9K
83014		<1%	1,464	$9K
86304		<1%	887	$9K
62322		<1%	13	$9K
83883		<1%	1,186	$8K
64405		<1%	26	$8K
96132		<1%	88	$8K
86431		<1%	2,048	$8K
82553		<1%	1,644	$8K
80177		<1%	965	$8K
80143		<1%	2,079	$8K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	519	$8K
84436		<1%	2,516	$8K
86160		<1%	666	$8K
ATP12		<1%	1,329	$8K
84295		<1%	5,685	$8K
75561		<1%	27	$8K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	205	$8K
99386		<1%	82	$8K
82627		<1%	442	$7K
ATP05		<1%	1,351	$7K
82533		<1%	581	$7K
76937		<1%	407	$7K
86706		<1%	1,022	$7K
73552		<1%	1,061	$7K
86235		<1%	276	$7K
0003A		<1%	423	$7K
86677		<1%	677	$7K
90739		<1%	106	$7K
82800		<1%	1,092	$7K
ATP18		<1%	1,298	$7K
24640		<1%	12	$7K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	1,638	$6K
0012A		<1%	376	$6K
87799		<1%	382	$6K
72132		<1%	484	$6K
36591		<1%	3,847	$6K
ATP13		<1%	1,304	$6K
51729		<1%	22	$6K
M0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring	<1%	82	$6K
83010		<1%	684	$6K
87209		<1%	461	$6K
86696		<1%	476	$6K
84165		<1%	1,293	$6K
11045		<1%	19	$5K
73700		<1%	124	$5K
90473		<1%	4,238	$5K
80197		<1%	2,257	$5K
82977		<1%	1,819	$5K
87899		<1%	594	$5K
92555		<1%	346	$5K
70360		<1%	102	$5K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	1,042	$5K
74740		<1%	25	$5K
90839		<1%	778	$5K
86200		<1%	582	$5K
86308		<1%	1,041	$5K
84480		<1%	661	$5K
73060		<1%	830	$5K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	14,787	$5K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	112	$5K
87206		<1%	1,149	$4K
G0009	Administration of pneumococcal vaccine	<1%	1,961	$4K
0011A		<1%	385	$4K
87045		<1%	699	$4K
87476		<1%	146	$4K
82951		<1%	388	$4K
87338		<1%	464	$4K
84134		<1%	498	$4K
96376		<1%	25,872	$4K
ATP16		<1%	765	$4K
86800		<1%	447	$4K
86870		<1%	84	$4K
86039		<1%	527	$4K
89051		<1%	1,056	$4K
51600		<1%	12	$4K
83921		<1%	479	$4K
86364		<1%	872	$4K
95913		<1%	103	$4K
76981		<1%	42	$3K
71101		<1%	117	$3K
92551		<1%	390	$3K
96409		<1%	83	$3K
92610		<1%	38	$3K
92650		<1%	55	$3K
78264		<1%	14	$3K
86617		<1%	285	$3K
82172		<1%	262	$3K
84466		<1%	369	$3K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	3,974	$3K
84155		<1%	3,214	$3K
H0046	Mental health services, not otherwise specified	<1%	67	$3K
90474		<1%	6,950	$3K
87177		<1%	460	$3K
86593		<1%	802	$3K
86255		<1%	320	$3K
86695		<1%	287	$3K
93298		<1%	183	$3K
0134A		<1%	84	$3K
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	418	$2K
80178		<1%	766	$2K
87449		<1%	418	$2K
94644		<1%	2,829	$2K
73660		<1%	70	$2K
87324		<1%	396	$2K
84144		<1%	161	$2K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	628	$2K
78306		<1%	12	$2K
83521		<1%	421	$2K
88312		<1%	166	$2K
88302		<1%	566	$2K
77470		<1%	13	$2K
80180		<1%	511	$2K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,163	$2K
0081A		<1%	66	$2K
85246		<1%	96	$2K
77338		<1%	27	$2K
64494		<1%	80	$2K
74178		<1%	12	$2K
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	1,835	$2K
J9045	Injection, carboplatin, 50 mg	<1%	597	$2K
96138		<1%	85	$2K
73521		<1%	28	$2K
83525		<1%	235	$2K
94668		<1%	13	$2K
96119		<1%	25	$2K
88300		<1%	763	$2K
96116		<1%	13	$2K
96121		<1%	13	$2K
99205	Prolong outpt/office vis	<1%	12	$2K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	36	$2K
86147		<1%	79	$2K
90678		<1%	110	$2K
90887		<1%	29	$2K
95911		<1%	12	$2K
72081		<1%	24	$2K
84305		<1%	110	$2K
77001		<1%	17	$2K
92556		<1%	100	$1K
87329		<1%	196	$1K
99397		<1%	149	$1K
87102		<1%	313	$1K
72128		<1%	136	$1K
86225		<1%	197	$1K
51798		<1%	783	$1K
84145		<1%	280	$1K
85245		<1%	61	$1K
80156		<1%	254	$1K
80175		<1%	227	$1K
74175		<1%	53	$1K
97163		<1%	13	$1K
99203	Doctor's office visit, new patient (routine)	<1%	12	$1K
93041		<1%	2,577	$1K
82952		<1%	389	$1K
82435		<1%	962	$1K
85347		<1%	418	$1K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	234	$1K
0053A		<1%	28	$1K
86709		<1%	143	$1K
85397		<1%	52	$1K
J2560	Injection, phenobarbital sodium, up to 120 mg	<1%	130	$1K
85651		<1%	453	$1K
90633		<1%	1,810	$1K
82677		<1%	56	$981.47
88313		<1%	240	$979.56
86336		<1%	66	$972.29
93321		<1%	2,582	$953.94
0082A		<1%	26	$939.36
94761		<1%	3,089	$937.69
85660		<1%	223	$921.09
72129		<1%	288	$914.53
83090		<1%	93	$869.17
80162		<1%	154	$861.23
83993		<1%	72	$854.01
74160		<1%	13	$852.46
J1836	Injection, metronidazole, 10 mg	<1%	234	$849.55
86644		<1%	75	$827.23
91319		<1%	158	$790.02
82088		<1%	26	$776.81
90696		<1%	3,837	$753.62
70310		<1%	444	$747.41
91305		<1%	2,637	$740.96
83498		<1%	39	$739.73
93280		<1%	41	$718.62
82397		<1%	62	$692.23
84425		<1%	70	$689.91
0121A		<1%	38	$688.05
91318		<1%	125	$653.60
0154A		<1%	14	$642.18
84630		<1%	86	$605.02
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	3,127	$594.90
90671		<1%	217	$588.84
86141		<1%	90	$585.35
84300		<1%	244	$563.74
82340		<1%	198	$561.46
86341		<1%	24	$561.33
83835		<1%	42	$542.62
82272		<1%	244	$540.62
ATP19		<1%	127	$513.45
86300		<1%	42	$511.65
86146		<1%	19	$496.94
84402		<1%	24	$488.04
96136		<1%	13	$466.00
76000		<1%	30	$431.84
85240		<1%	27	$431.79
81596		<1%	47	$428.65
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	160	$424.20
85613		<1%	69	$420.82
80299		<1%	55	$409.48
80230		<1%	12	$408.12
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	1,944	$386.40
88142		<1%	28	$378.42
84244		<1%	25	$373.98
94645		<1%	507	$371.35
70320		<1%	414	$354.88
72220		<1%	14	$349.64
87350		<1%	55	$344.49
90682		<1%	14	$319.15
86707		<1%	44	$317.97
11719		<1%	12	$317.11
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	2,661	$307.46
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	187	$299.29
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	16	$297.04
84154		<1%	41	$292.16
J1790	Injection, droperidol, up to 5 mg	<1%	1,048	$283.16
81050		<1%	205	$266.84
82103		<1%	26	$259.05
J1940	Injection, furosemide, up to 20 mg	<1%	336	$248.97
93299		<1%	12	$239.62
89055		<1%	99	$236.92
J9190	Injection, fluorouracil, 500 mg	<1%	1,528	$228.37
86258		<1%	15	$221.52
93750		<1%	13	$210.62
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	19	$173.80
82390		<1%	36	$172.04
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,810	$171.22
94010		<1%	18	$170.84
90620		<1%	16	$170.36
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	194	$164.44
80185		<1%	57	$159.30
85384		<1%	30	$158.82
84432		<1%	12	$156.04
73000		<1%	15	$154.32
86301		<1%	39	$146.80
86335		<1%	12	$142.03
90685		<1%	2,051	$139.83
82525		<1%	12	$132.30
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	5,520	$121.27
86694		<1%	14	$118.72
36416		<1%	9,034	$113.17
83930		<1%	45	$107.40
87101		<1%	14	$105.03
82360		<1%	15	$102.15
88360		<1%	14	$100.14
80183		<1%	13	$95.69
82375		<1%	13	$94.93
36410		<1%	41	$81.95
83935		<1%	34	$81.84
93282		<1%	12	$76.50
72020		<1%	25	$70.53
82787		<1%	13	$64.60
87106		<1%	13	$53.25
88311		<1%	82	$51.00
86063		<1%	14	$35.70
86008		<1%	35	$32.72
87176		<1%	14	$32.16
90710		<1%	4,072	$31.84
94760		<1%	2,791	$31.77
84478		<1%	212	$29.60
ATP20		<1%	14	$25.99
74022		<1%	13	$25.81
J9267	Injection, paclitaxel, 1 mg	<1%	348	$23.13
90680		<1%	11,137	$22.02
87015		<1%	16	$18.27
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	7,657	$13.14
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	3,286	$7.14
91307		<1%	1,384	$5.64
C9113	Injection, pantoprazole sodium, per vial	<1%	210	$4.99
C1769	Guide wire	<1%	4,728	$3.58
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	7,156	$2.13
J1171	Injection, hydromorphone, 0.1 mg	<1%	228	$1.44
91300		<1%	8,039	$0.08
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	3,426	$0.08
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	1,652	$0.05
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	454	$0.05
99153	Mod sedat endo service >5yrs	0%	3,210	$0.00
90723		0%	4,732	$0.00
90744		0%	1,262	$0.00
90698		0%	6,756	$0.00
90697		0%	3,950	$0.00
81511		0%	184	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	470	$0.00
90634		0%	5,967	$0.00
J7999	Compounded drug, not otherwise classified	0%	213	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	67	$0.00
91301		0%	247	$0.00
G0103	Prostate cancer screening; prostate specific antigen test (psa)	0%	259	$0.00
93320		0%	179	$0.00
C1732	Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping	0%	27	$0.00
J0461	Injection, atropine sulfate, 0.01 mg	0%	42	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	687	$0.00
A4648	Tissue marker, implantable, any type, each	0%	26	$0.00
91303		0%	561	$0.00
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	0%	38	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	13	$0.00
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	0%	17	$0.00
C1893	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away	0%	13	$0.00
90688		0%	567	$0.00
91315		0%	45	$0.00
G8998	Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting	0%	12	$0.00
90381		0%	24	$0.00
J0456	Injection, azithromycin, 500 mg	0%	16	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	13	$0.00
91317		0%	13	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	1,494	$0.00
J2359	Injection, olanzapine, 0.5 mg	0%	13	$0.00
99152		0%	4,009	$0.00
90648		0%	6,100	$0.00
90700		0%	1,822	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	132	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	65	$0.00
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	0%	129	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	31	$0.00
91312		0%	2,102	$0.00
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	0%	33	$0.00
01992		0%	78	$0.00
91313		0%	82	$0.00
91308		0%	185	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	29	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	76	$0.00
Q0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg	0%	37	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	73	$0.00
90611		0%	28	$0.00
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	34	$0.00
76376		0%	93	$0.00
77387		0%	115	$0.00
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	0%	12	$0.00
90713		0%	40	$0.00
C1776	Joint device (implantable)	0%	40	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	39	$0.00
J2310	Injection, naloxone hydrochloride, per 1 mg	0%	13	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	40	$0.00
J9370	Vincristine sulfate, 1 mg	0%	21	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMARTIN, LAURIE (CHIEF FINANCIAL OFFICER)

Same official

Other billing entities under MARTIN, LAURIE

Full network →

Provider	Location	Paid
Vermont Dental Care	Barre, VT	$859K
Baystate Medical Center, INC.	Springfield, MA	$156K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.